Paradigm doses first subjects in Phase III knee osteoarthritis trial
The trial will evaluate the change in pain and function following subcutaneous injections of PPS versus placebo.
Musculoskeletal Disorders
Latest in
Musculoskeletal Disorders
Saol doses first subject in Phase II limb spasticity treatment trial
The trial will evaluate the safety, pharmacokinetics and efficacy of SL-1002 in adults with limb spasticity.
Transcenta doses first subject in Phase I osteoporosis drug trial in China
The trial will assess the safety, tolerability and pharmacokinetics of TST002 to treat individuals with osteoporosis.
Acadia reports data from Phase II acute postoperative pain treatment trial
The trial failed to meet the primary endpoint but showed a trend favouring treatment with 400mg ACP-044.
Mapping Endpoints: Is the 6-minute walk test still the best Pompe disease clinical trial endpoint?
The 6-minute walk test has long been the consensus primary measure for Pompe disease drug studies, but some experts are…
By
Aptinyx concludes enrolment in Phase IIb fibromyalgia therapy trial
The change in average daily pain scores from baseline to week 12 is the primary endpoint of the trial.
Neurana concludes subject enrolment in trial of muscle spasm therapy
Subject-reported pain at day 14 due to acute back spasm is the primary goal of the trial.
Novartis aiming to expand patient reach for world’s most expensive drug, Zolgensma
The US FDA's clinical hold on Zolgensma did not just delay Novartis in developing the drug, but allowed its competitors…
By